EMPA-KIDNEY: meta-analysis results
EMPA-KIDNEY results: Empagliflozin reduces kidney disease progression and cardiovascular deaths
Tag der offenen Tür an der Empa Dübendorf
EMPA-KIDNEY results November 2022
EMPA CKD - 3 min trial summary
EMPA-KIDNEY: Introduction to the trial
Empa: Materials and Technologies to Shape the Future
EMPA KIDNEY results: Flozins for all CKD with Dr Will Herrington
Blocher im EMPA-Test
It Is Difficult To Explain The Joy Africa Brings To Me | Aribatu Idirisu
Empa - Materials and technologies for a sustainable future
Welcome at the Empa Campus in Dübendorf!
Welcome at Empa St. Gallen!
ESC TV On the Road - #AHA22 - DCP and EMPA-KIDNEY trials
Cardiovascular Benefits with SGLT2 Inhibition: EMPA-REG
Impact of EMPA-REG OUTCOME
EHJ Today - The EMPA-REG OUTCOME Trial
Empa Materials Science and Technology (What Is Series)
Die Empa - Das Buch
Emerging data from EMPA-KIDNEY study